OR WAIT null SECS
© 2023 MJH Life Sciences and Contemporary Pediatrics. All rights reserved.
© 2023 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
January 25, 2023
After addressing a 2021 CRL, Verrica Pharmaceuticals vies for the agent to become the first drug approved to treat the common skin infection.
January 16, 2023
A cross-sectional study showed cannabis ingestion has been the cause of 1 in every 3 pediatric poisoning hospitalizations in provinces that sell edibles.
December 21, 2022
New surveillance data from the 2021-22 influenza show the impact of coinfection among younger patients.
December 19, 2022
An economic analysis of a clinical sleep intervention suggests it may provide a step toward improved health equity.
October 21, 2022
New 16-week data from the SPROUT trial show the PDE4 inhibitor may be highly efficacious in children and adolescents.
June 27, 2022
New data from ECZTRA 6 show improved sleep quality, itch relief and quality of life among teenagers treating atopic dermatitis with the IL-13 inhibitor.